# Human Papilloma Virus Vaccine Consistency and Non-inferiority Trial in Young Adult Women With GSK Bio HPV-16/18

> **NCT00169494** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 770 (actual)

## Conditions studied

- Infections, Papillomavirus

## Interventions

- **BIOLOGICAL:** HPV-16/18 L1/AS04

## Key facts

- **NCT ID:** NCT00169494
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2005-07
- **Final completion:** 2005-07
- **Target enrollment:** 770 (ACTUAL)
- **Last updated:** 2016-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00169494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00169494, "Human Papilloma Virus Vaccine Consistency and Non-inferiority Trial in Young Adult Women With GSK Bio HPV-16/18". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00169494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*